tiprankstipranks
Trending News
More News >
AnaptysBio Inc (ANAB)
NASDAQ:ANAB
US Market

AnaptysBio (ANAB) Income Statement

Compare
640 Followers

AnaptysBio Income Statement

Last quarter (Q3 2025), AnaptysBio's total revenue was $76.32M, an increase of 154.26% from the same quarter last year. In Q3, AnaptysBio's net income was $15.11M. See AnaptysBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 91.28M$ 17.16M$ 10.29M$ 63.17M$ 75.00M
Gross Profit
$ -72.56M$ -115.13M$ -78.51M$ -35.32M$ -5.03M
Operating Expenses
$ 42.39M$ 49.28M$ 36.64M$ 21.49M$ 18.85M
Depreciation and Amortization
$ 2.40M$ 652.00K$ 2.33M$ 2.09M$ 559.00K
EBITDA
$ -92.74M$ -156.42M$ -105.26M$ -55.71M$ -19.37M
Operating Income
$ -114.95M$ -164.41M$ -115.15M$ -56.81M$ -23.88M
Other Income/Expenses
$ -30.28M$ 788.00K$ -13.55M$ -982.00K$ 3.95M
Pretax Income
$ -145.23M$ -163.62M$ -128.70M$ -57.80M$ -19.93M
Net Income
$ -145.23M$ -163.62M$ -128.72M$ -57.80M$ -19.93M
Per Share Metrics
Basic EPS
$ -5.12$ -6.08$ -4.57$ -2.11$ -0.73
Diluted EPS
$ -5.12$ -6.08$ -4.57$ -2.11$ -0.73
Weighted Average Shares Outstanding
28.38M 26.92M 28.16M 27.43M 27.30M
Weighted Average Shares Outstanding (Diluted)
28.38M 26.92M 28.16M 27.43M 27.30M
Currency in USD

AnaptysBio Earnings and Revenue History